跳至主要内容
临床试验/2024-520299-86-00
2024-520299-86-00招募中4 期

Prednisone treatment in acute interstitial nephritis - a randomized prospective trial (PRAISE)

Region Midtjylland9 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2025年1月13日最近更新:
相关药物

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
110
试验地点
9
主要终点
eGFR at 3 months

研究概览

简要总结

To investigate the effect of prednisolone treatment in acute interstitial nephritis.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65+ years(65+ Years, 18-64 Years)
接受健康志愿者

入选标准

  • Biopsi proven acute interstitial nephritis (AIN), Clinical suspision of AIN, Age of minimum 18 years, One of the two following criteria: Creatinine > 120 mmol/l or Creatinine increase of > 30 mmol/l or 1,5 x creatinine-increase, Women with child bearing potential

排除标准

  • Not able to give consent. • IImmunosuppressive therapy within 3 months • Autoimmune disease. • Allergy or intolerance towards MP eller prednisolone. • Pregnancy or nursing • Active cancer except basal celle carcinoma. • Terminal illness with life expectancy of less than 6 months • CKD 4 or 5 • Previous participation • AIN associated with glomerulonefritis, sarcoidosis eller inherited interstitial kidney diseases

结局指标

主要结局

eGFR at 3 months

eGFR at 3 months

次要结局

  • Kidney function (eGFR) at 12 months, CKD stage, Number og patients in dialysis, Effekt of treatment-delay on outcome, Urinary biomarkers, Questionaire: SF36 score, The predictive value of histopathological evaluation, Safety endpoints: P-glukose, Infections, Submissions

研究者

发起方
Region Midtjylland
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Jesper Nørgaard Bech

Scientific

Region Midtjylland

研究点 (9)

Loading locations...

相似试验